Systematic documentation of new vaccine introduction in selected countries of the Latin American Region

Vaccine

Volumn 31, Issue SUPPL.3, 2013, Pages

  de Oliveira, Lúcia H ^a   Toscano, Cristiana M ^b   Sanwogou, N Jennifer ^a   Ruiz Matus, Cuauhtémoc ^a   Tambini, Gina ^a   Roses Periago, Mirta ^a   Andrus, Jon K ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Evidence based decision making; Immunization policy; Immunization programs; New vaccines; Pneumococcal conjugate vaccines; Rotavirus vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

BOLIVIA; BRAZIL; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; IMMUNIZATION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NICARAGUA; PERU; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; ROTAVIRUS INFECTION; SOUTH AND CENTRAL AMERICA; VENEZUELA;

BOLIVIA; BRAZIL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DOCUMENTATION; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; NICARAGUA; PAN AMERICAN HEALTH ORGANIZATION; PERU; PNEUMOCOCCAL VACCINES; PUBLIC HEALTH SURVEILLANCE; ROTAVIRUS VACCINES; VACCINES, CONJUGATE; VENEZUELA;

EID: 84879221441     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.032     Document Type: Review

References (47)

1. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(1):11-22.
2. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
3. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007, 82(12):93-104.
4. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. Wkly Epidemiol Rec 2006, 81(47):445-452.
5. PAHO Resolution CD47.R10. 47th Directing Council 2006, Pan American Health Organization.
6. PAHO XIX Technical Advisory Group on Vaccine-preventable diseases meeting. Pan American Health Organization; 2011.
7. Andrus J.K., Crouch A.A., Fitzsimmons J., Vicari A., Tambini G. Immunization and the Millennium Development Goals: progress and challenges in Latin America and the Caribbean. Health Aff (Millwood) 2008, 27(2):487-493.
8. Andrus J.K., Toscano C.M., Lewis M., Oliveira L., Ropero A.M., Davila M., Fitzsimmons J.W. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Rep 2007, 122(6):811-816.
9. WHO Vaccine introduction guidelines: Adding a vaccine to a national immunization programme: decision and implementation. WHO/IVB/0518 2005, World Health Organization.
10. PAHO Introduction and implementation of new vaccines: field guide. Publicación científica y técnica No. 632 2010, Pan American Health Organization.
11. Bolivia: Plan de introducción de vacuna contra rotavirus 2007-2012 2008, Ministerio de Salud y Deportes/Programa Ampliado de Inmunización, La Paz, Bolivia.
12. Etiene K., Rowlinson E. Carga económica de rotavirus en niños hospitalizados por EDA. In: Edited by communication p. La Paz 2006, Cortesía del PAI de Bolivia, Bolivia.
13. Rocha M. Carga económica de la enfermedad diarreica en la comunidad en niños menores de 5 anos en Bolivia. In: personal communication. Edited by Bolivia CdPd 2007.
14. Smith E.R., Rowlinson E.E., Iniguez V., Etienne K.A., Rivera R., Mamani N., Rheingans R., Patzi M., Halkyer P., Leon J.S. Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective. Vaccine 2011, 29(38):6704-6711.
15. GAVI: GAVI Fact Sheet Bolivia. In. Edited by GAVI; 2008.
16. Rotavirus vaccines. Wkly Epidemiol Rec 2007, 82(32):285-295.
17. WHO NICARAGUA - WHO estimates of child deaths due to rotavirus infection 2006, World Health Organization, Geneva, Switzerland.
18. Espinoza F., Paniagua M., Hallander H., Hedlund K.O., Svensson L. Prevalence and characteristics of severe rotavirus infections in Nicaraguan children. Ann Trop Paediatr 1997, 17(1):25-32.
19. Espinoza F., Paniagua M., Hallander H., Svensson L., Strannegard O. Rotavirus infections in young Nicaraguan children. Pediatr Infect Dis J 1997, 16(6):564-571.
20. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(9619):1181-1189.
21. Kane E.M., Turcios R.M., Arvay M.L., Garcia S., Bresee J.S., Glass R.I. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica 2004, 16(6):371-377.
22. Nicaragua Plan for the Introduction of the Rotavirus Vaccine in Nicaragu, 2006 2006, Ministry of Health, Managua, Nicaragua.
23. Amador J.J., Vicari A., Turcios-Ruiz R.M., Melendez D.A., Malek M., Michel F., et al. Outbreak of rotavirus gastroenteritis with high mortality, Nicaragua, 2005. Rev Panam Salud Publica 2008, 23(4):277-284.
24. Nicaragua Recomendaciones del Comité Nacional de Prácticas de Inmunización sobre la Introducción de la Vacuna contra Rotavirus en Nicaragua 2006, CNPI, Managua.
25. Nicaragua Comprehensive Multi-Year Plan for the National Immunization Programme 2007-2011 (cMYP) 2007, Ministry of Health, Managua, Nicaragua.
26. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301(21):2243-2251.
27. Mast T.C., Khawaja S., Espinoza F., Paniagua M., Palacio Del Carmen L., Cardellino A., Sanchez E. Case-control Study of the Effectiveness of Vaccination With Pentavalent Rotavirus Vaccine in Nicaragua. Pediatr Infect Dis J 2011, 30(11):e209-e215.
28. Orozco M., Vasquez J., Pedreira C., De Oliveira L.H., Amador J.J., Malespin O., Andrus J., Tate J., Parashar U., Patel M Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis 2009, 200(Suppl. 1):S125-S130.
29. Sartori A.M., Valentim J., de Soarez P.C., Novaes H.M. Rotavirus morbidity and mortality in children in Brazil. Rev Panam Salud Publica 2008, 23(2):92-100.
30. Siqueira A.A., Santelli A.C., Alencar L.R., Dantas M.P., Dimech C.P., Carmo G.M., et al. Outbreak of acute gastroenteritis in young children with death due to rotavirus genotype G9 in Rio Branco, Brazilian Amazon region, 2005. Int J Infect Dis 2010, 14(10):e898-e903.
31. BRASIL. Ministério da Saúde: PORTARIA N° 2587, DE 30 DE OUTUBRO DE 2008: Dispõe sobre a Comissão de Incorporação de Tecnologias do Ministério da Saúde e vincula sua gestão à Secretaria de Ciência, Tecnologia e Insumos Estratégicos. In. Edited by Ministério da Saúde, vol. 2587. Brasilia, Brazil; 2008.
32. FIOCRUZ/Ministry of Health: HEIC Report. In., vol. 1. Rio de Janeiro, Brazil; Oswaldo Cruz Foundation; 2010: 1-17.
33. Milstien J.B., Gaule P., Kaddar M Access to vaccine technologies in developing countries: Brazil and India. Vaccine 2007, 25(44):7610-7619.
34. Justino M.C., Linhares A.C., Lanzieri T.M., Miranda Y., Mascarenhas J.D., Abreu E., et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belem, Brazil. Pediatr Infect Dis J 2011, 30(5):396-401.
35. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M., Germano E.M., Correia N.B., Cuevas L.E., Parashar U.D., Cunliffe N.A., Nakagomi T. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010, 201(3):363-369.
36. Safadi M.A., Berezin E.N., Munford V., Almeida F.J., de Moraes J.C., Pinheiro C.F., Racz M.L. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil. Pediatr Infect Dis J 2010, 29(11):1019-1022.
37. Gurgel R.Q., Ilozue C., Correia J.B., Centenari C., Oliveira S.M., Cuevas L.E. Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health 2011, 16(9):1180-1184.
38. Lanzieri T.M., Costa I., Shafi F.A., Cunha M.H., Ortega-Barria E., Linhares A.C., Colindres R.E. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J 2010, 29(7):673-675.
39. Lanzieri T.M., Linhares A.C., Costa I., Kolhe D.A., Cunha M.H., Ortega-Barria E., Colindres R.E. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis 2011, 15(3):e206-e210.
40. do Carmo G.M., Yen C., Cortes J., Siqueira A.A., de Oliveira W.K., Cortez-Escalante J.J., et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011, 8(4):e1001024.
41. WHO PERU - WHO estimates of child deaths due to rotavirus infection 2006, World Health Organization, Geneva, Switzerland.
42. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., Lee E., Mulholland K., Levine O.S., Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902.
43. PRAES: La carga de enfermedad y lesiones en el Peru In. Lima: PRAES USAID-Peru. 2008.
44. Sinha A., Constenla D., Valencia J.E., O'Loughlin R., Gomez E., de la Hoz F., Valenzuela M.T., de Quadros C.A. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis. Rev Panam Salud Publica 2008, 24(5):304-313.
45. Peru: La vacuna contra neumococo, sustentación técnica econõmica de su introducción al esquema regular. In. Lima: Ministerio de Salud; 2007.
46. WHO VENEZUELA - WHO estimates of child deaths due to rotavirus infection 2006, World Health Organization, Geneva, Switzerland.
47. Jauregui B., Sinha A., Clark A.D., Bolanos B.M., Resch S., Toscano C.M., Matus C.R., Andrus J.K. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 2011, 29(5):1099-1106.